Evidence map›Paper›PMID 34606519›Full record

ArticlePLoS neglected tropical diseases2021

Efficacy of targeted indoor residual spraying with the pyrrole insecticide chlorfenapyr against pyrethroid-resistant Aedes aegypti.

Azael Che-Mendoza, Gabriela González-Olvera, Anuar Medina-Barreiro, Carlos Arisqueta-Chablé, Wilberth Bibiano-Marin, Fabián Correa-Morales, Oscar D Kirstein, Pablo Manrique-Saide, Gonzalo M Vazquez-Prokopec

Registry-linked trialOpen access · goldAbstract readEvaluation Study
In one paragraph

Article in PLoS neglected tropical diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04343521 (Quantifying the Epidemiological Impact of Targeted Indoor Residual Spraying on Aedes-borne Diseases), which is not on this map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04343521 nacompletednot on this map

Quantifying the Epidemiological Impact of Targeted Indoor Residual Spraying on Aedes-borne Diseases

TypeinterventionalSponsorEmory UniversityRan2020 to 2024Enrolled4,461ConditionsAedes-borne Diseases, Dengue, Chikungunya, ZikaArmsTargeted Indoor Residual Spraying (TIRS)
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Climate change and budget cuts: Facing theMalariaWorld journal · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Azael Che-MendozaUnidad Colaborativa para Bioensayos Entomologicos, Universidad Autonoma de Yucatan, Merida, Yucatan, Mexico.ORCID 0000-0001-9954-3678
Gabriela González-OlveraUnidad Colaborativa para Bioensayos Entomologicos, Universidad Autonoma de Yucatan, Merida, Yucatan, Mexico.ORCID 0000-0002-1555-8336
Anuar Medina-BarreiroUnidad Colaborativa para Bioensayos Entomologicos, Universidad Autonoma de Yucatan, Merida, Yucatan, Mexico.
Carlos Arisqueta-ChabléUnidad Colaborativa para Bioensayos Entomologicos, Universidad Autonoma de Yucatan, Merida, Yucatan, Mexico.ORCID 0000-0003-2512-9962
Wilberth Bibiano-MarinUnidad Colaborativa para Bioensayos Entomologicos, Universidad Autonoma de Yucatan, Merida, Yucatan, Mexico.ORCID 0000-0002-5975-4056
Fabián Correa-MoralesCentro Nacional de Programas Preventivos y Control de Enfermedades (CENAPRECE) Secretaria de Salud Mexico, Ciudad de Mexico, Mexico.ORCID 0000-0002-6193-1242
Oscar D KirsteinDepartment of Environmental Sciences, Emory University, Atlanta, Georgia, United States of America.ORCID 0000-0003-4765-7483
Pablo Manrique-SaideUnidad Colaborativa para Bioensayos Entomologicos, Universidad Autonoma de Yucatan, Merida, Yucatan, Mexico.ORCID 0000-0002-0565-1342
Gonzalo M Vazquez-ProkopecDepartment of Environmental Sciences, Emory University, Atlanta, Georgia, United States of America.ORCID 0000-0002-0710-270X
Autonomous University of Yucatán · MXEmory University · USSecretaria de Salud · MX

Funding

Quanitifying the Epidemiological Impact of Targeted Indoor Residual Spraying on Aedes-borne DiseasesU01AI148069 · NIAID · EMORY UNIVERSITY · PI VAZQUEZ PROKOPEC, GONZALO MARTIN · 2020 to 2024
$6.4M
NIAID NIH HHS U01 AI148069
6 · The paper itself

Abstract

backgroundThere is an increased need to mitigate the emergence of insecticide resistance and incorporate new formulations and modes of application to control the urban vector Aedes aegypti. Most research and development of insecticide formulations for the control of Ae. aegypti has focused on their peridomestic use as truck-mounted ULV-sprays or thermal fogs despite the widespread knowledge that most resting Ae. aegypti are found indoors. A recent modification of indoor residual spraying (IRS), termed targeted IRS (TIRS) works by restricting applications to 1.5 m down to the floor and on key Ae. aegypti resting sites (under furniture). TIRS also opens the possibility of evaluating novel residual insecticide formulations currently being developed for malaria IRS.

methodsWe evaluated the residual efficacy of chlorfenapyr, formulated as Sylando 240SC, for 12 months on free-flying field-derived pyrethroid-resistant Ae. aegypti using a novel experimental house design in Merida, Mexico. On a monthly basis, 600 female Ae. aegypti were released into the houses and left indoors with access to sugar solution for 24 hours. After the exposure period, dead and alive mosquitoes were counted in houses treated with chlorfenapyr as well as untreated control houses to calculate 24-h mortality. An evaluation for these exposed cohorts of surviving mosquitoes was extended up to seven days under laboratory conditions to quantify "delayed mortality".

resultsMean acute (24-h) mortality of pyrethroid-resistant Ae. aegypti ranged 80-97% over 5 months, dropping below 30% after 7 months post-TIRS. If delayed mortality was considered (quantifying mosquito mortality up to 7 days after exposure), residual efficacy was above 90% for up to 7 months post-TIRS application. Generalized Additive Mixed Models quantified a residual efficacy of chlorfenapyr of 225 days (ca. 7.5 months).

conclusionsChlorfenapyr represents a new option for TIRS control of Ae. aegypti in urban areas, providing a highly-effective time of protection against indoor Ae. aegypti females of up to 7 months.

Indexed as

Insecticide ResistanceAedesAnimalsFemaleHousingHumansInsecticidesMalariaMaleMosquito ControlMosquito VectorsPyrethrinschlorfenapyrInsecticidesPyrethrins

Identifiers

PMID34606519
PMCPMC8516273
OpenAlexW3202405803

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.